scispace - formally typeset
Search or ask a question
Institution

Hospital Universitario La Paz

HealthcareMadrid, Spain
About: Hospital Universitario La Paz is a healthcare organization based out in Madrid, Spain. It is known for research contribution in the topics: Population & Medicine. The organization has 8960 authors who have published 11499 publications receiving 191509 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The goal was to develop multinational estimates for minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS) for patients with symptomatic Ehlers-Danlos syndrome.
Abstract: The ability to interpret scores from patient-reported outcome measures at the individual patient level depends on the availability of valid, clinically meaningful benchmarks of response and state attainment. The goal was to develop multinational estimates for minimal clinically important improvement (MCII) and patient acceptable symptomatic state (PASS). A multinational sample of patients with osteoarthritis (OA) was evaluated before and 4 weeks after treatment with nonsteroidal antiinflammatory drugs. Patients completed either the Western Ontario and McMaster Osteoarthritis Index (WOMAC) numerical rating scale 3.1 (hip and knee OA) or the Australian/Canadian Index (AUSCAN) numerical rating scale 3.1 (hand OA) before and after treatment. Patients rated the clinical importance of their response to treatment and their satisfaction with the health state achieved, from which multinational MCII and PASS estimates were calculated for both the WOMAC and AUSCAN indices. A total of 609 patients from 7 countries participated in the study. MCII and PASS estimates varied slightly by instrument and subscale. Absolute (percentage) change for MCII ranged 6-9 (10% to 17%) for WOMAC and 4-9 (8% to 15%) for AUSCAN. PASS estimates ranged 39-48 for WOMAC and 38-45 for AUSCAN. Some between-country variation was observed in MCII and PASS. Preliminary multinational estimates for MCII and PASS have been developed for several countries. Further research is required to evaluate the robustness, temporal consistency, and age- and sex-dependency of the preliminary estimates as well as their generalizability to other countries, languages, cultures, regions, and other condition-specific outcome measures.

79 citations

Journal ArticleDOI
TL;DR: Cell-based therapy has demonstrated safety and efficacy in experimental animal models of stroke, as well as safety in stroke patients, but various questions remain regarding the therapeutic window, dosage, route of administration, and the most appropriate cell type and source.
Abstract: Cell-based therapy has demonstrated safety and efficacy in experimental animal models of stroke, as well as safety in stroke patients. However, various questions remain regarding the therapeutic window, dosage, route of administration, and the most appropriate cell type and source, as well as mechanisms of action and immune-modulation to optimize treatment based on stem cell therapy. Various delivery routes have been used in experimental stroke models, including intracerebral, intraventricular, subarachnoid, intra-arterial, intraperitoneal, intravenous, and intranasal routes. From a clinical point of view, it is necessary to demonstrate which is the most feasible, safest, and most effective for use with stroke patients. Therefore, further experimental studies concerning the safety, efficacy, and mechanisms of action involved in these therapeutic effects are required to determine their optimal clinical use.

78 citations

Journal ArticleDOI
TL;DR: Ultrasonography with power Doppler shows that the ultrasound appearances of subclinical enthesitis in psoriasis differ from the subclinicalEnthesopathy in PsA, with PsA patients having more PD, suggestive of a more inflammatory or vascular process in psA.
Abstract: Objective Subclinical enthesopathy is recognised in both psoriasis and psoriatic arthritis (PsA). This study used ultrasonography with power Doppler (PD) to test the hypothesis that subclinical enthesopathy in PsA was associated with an ‘inflammatory’ or vascular phenotype compared to that seen in psoriasis. Methods 100 patients with a mean age of 46.3 years (SD 15) (42 with psoriasis and 58 with PsA) and 23 matched healthy controls (HC) from two centres were included. 1230 lower limb entheses were scanned by ultrasonographers blinded to clinical details. Both inflammatory and chronic features of enthesopathy were scored. Results Psoriasis patients (with or without arthritis) were more likely to express a vascular phenotype, with higher inflammation-related enthesopathy scores than HC (for inflammation p Conclusions This study shows that the ultrasound appearances of subclinical enthesitis in psoriasis differ from the subclinical enthesitis in PsA, with PsA patients having more PD. This is suggestive of a more inflammatory or vascular process in PsA, and offers potentially novel insights into the progression from skin to joint disease in psoriasis.

78 citations


Authors

Showing all 9020 results

NameH-indexPapersCitations
Jaakko Tuomilehto1151285210682
Vincent Soriano8776234084
Lina Badimon8668235774
Francisco J. Blanco8478933319
Michael A. Gatzoulis8247832562
Jose Lopez-Sendon8146041809
Victor Moreno8063531511
Joaquín Dopazo7539624790
Fernando Rodríguez-Artalejo7451223296
José R. Banegas7442128249
Michael Becker7231718189
Gianfranco Ferraccioli7040226515
Maria-Victoria Mateos6648024278
Manuel Romero-Gómez6442019006
Eulogio García6327015354
Network Information
Related Institutions (5)
Carlos III Health Institute
30K papers, 849K citations

84% related

University of Navarra
26.6K papers, 747.2K citations

83% related

Autonomous University of Barcelona
80.5K papers, 2.3M citations

80% related

University of Barcelona
108.5K papers, 3.7M citations

80% related

University Medical Center Groningen
30.3K papers, 967K citations

80% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202322
202272
20211,335
20201,186
2019889
2018670